Clinical Trials on Chiari I Malformation

Total 2762 results

Hongqi Zhang, MD
General Hospital of Chinese Armed Police Forces; Beijing Tiantan Hospital; Chinese... and other collaborators

Unknown

Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas (SUIT-SAVM)

Spinal Cord Vascular Diseases

China
Cynosure, Inc.

Completed

Skintel Integration Study

Skin Type From I-VI on Non-hair Bearing Skin
Xian Children's Hospital

Completed

Application of I-gel Laryngeal Mask Airway in Pediatric Patients

the Efficacy and Performance of the Pediatric I-gel Mask

China
Alder Hey Children's NHS Foundation Trust

Recruiting

Long-term Qualitative and Quantitative Outcomes of Children With Hirschsprung's Disease and Anorectal Malformations (ALOHA)

Anorectal Malformations | Hirschsprung Disease

United Kingdom
Fondazione Policlinico Universitario Agostino Gemelli...
Azienda Ospedaliero-Universitaria di Parma; Ministero della Salute, Italy; Ospedale...

Recruiting

Artificial Intelligence Algorithm for the Screening of Abnormal Fetal Brain Findings at First Trimester Ultrasound Scan (AIRFRAME)

Brain Malformation | Fetal Anomaly

Italy
University of Zurich

Unknown

Linking Digital Smartphone Behaviour With Brain Function (SmartSurgery)

Brain Tumor | Arteriovenous Malformations | Hydrocephalus

Switzerland
King's College London

Completed

Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries

Congenital Diaphragmatic Hernia | Gastroschisis | Intestinal Atresia | Hirschsprung Disease | Oesophageal Atresia | Anorectal Malformation | Exomphalos

United Kingdom
University of Pennsylvania

Completed

Graded TTCE for Post-Embolization PAVM Monitoring

Hereditary Hemorrhagic Telangiectasia (HHT)

United States
Children's Hospital of Philadelphia

Completed

Effects of Additional Fentanyl to Epidural Bupivacaine for Post-Thoracotomy Pain in Neonates

Congenital Cystic Adenomatoid Malformation

United States
Allergy Therapeutics

Completed

Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Efficacy and Safety/Tolerability of Grass MATA MPL

Type I Hypersensitivity

United States, Canada, United Kingdom, Austria
Allergy Therapeutics

Completed

Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen

Type I Hypersensitivity

United States
Al-Azhar University

Enrolling by invitation

Maxillary Canine Retraction Assisted With Micro-osteoperforations Versus Injectable Platelet Rich Fibrin

Effects of; Movement of Teeth Assiste Wit MOPS and I-prf

Egypt
Allergy Therapeutics

Completed

Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test

Type I Hypersensitivity

United States
Lexent Bio, Inc.

Terminated

Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"

Neoplasms, Non-hematologic - Stage I-III

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Bipolar I Disorder

United States, Argentina
Allergy Therapeutics

Completed

Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen

Type I Hypersensitivity

Germany
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Efficacy and Safety/Tolerability of Ragweed MATA MPL

Type I Hypersensitivity

Canada, United States
Allergy Therapeutics

Completed

Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen

Type I Hypersensitivity

United States
Boston Children's Hospital

Completed

Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.

Vascular Anomalies

United States
Allergy Therapeutics

Withdrawn

Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen

Type I Hypersensitivity

Canada
University Hospital, Ghent

Terminated

Nitrous Oxide - Sevoflurane-Remifentanil Interaction

ASA Class I/II Patients Scheduled for Surgery Under General Anesthesia

Belgium
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing

Type I Hypersensitivity

United States
Herlev Hospital

Unknown

The Relationship Between the Growth Hormone (GH)- Insulin Like Growth Factor I (IGF-I) System and the Inflammatory System in Healthy Normal Persons

Interaction Between the GH/IGF-I System and the Immune-system

Denmark
University of Iowa

Completed

Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

Lymphatic Malformations

United States
The Hospital for Sick Children

Completed

Determining the Extent of Diffusion Tensor Abnormalities in Focal Cortical Dysplasia (FCP)

Epilepsy | Focal Cortical Dysplasia

Canada
Imperial College London

Completed

Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs

Hereditary Hemorrhagic Telangiectasia | Pulmonary Arteriovenous Malformations

United Kingdom
Rush University Medical Center
The Ryan Licht Sang Bipolar Foundation

Completed

Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS) (BRAINS)

Bipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective Disorder

United States
Novartis Pharmaceuticals

Recruiting

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. (EPIK-L1)

Lymphatic Malformations

Spain, France, Germany, Australia, United States
Stanford University
Ann & Robert H Lurie Children's Hospital of Chicago

Completed

Sildenafil for the Treatment of Lymphatic Malformations

Lymphatic Diseases | Lymphatic Malformations

United States
Richard JH Smith

Completed

OK432 (Picibanil) in the Treatment of Lymphatic Malformations

Lymphatic Malformations

United States
Medical College of Wisconsin

Terminated

Selenium in the Treatment of Complicated Lymphatic Malformations

Lymphatic Malformations

United States
AbbVie

Recruiting

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Depression | Bipolar I Disorder

United States, Puerto Rico, Russian Federation
Ain Shams University

Completed

I-gel Versus Air-Q LMA for Pediatric Patients

Easy Insertion, Complications Ans Suitability of i Gel and Air Q LMA

Egypt
University of British Columbia

Completed

Lurasidone and Cognition in Bipolar I Disorder

Bipolar I Disorder

Canada
University of Pittsburgh
National Alliance for Research on Schizophrenia and Depression

Completed

L-Carnosine for Bipolar I Disorder

Bipolar I Disorder

United States
Vastra Gotaland Region
AstraZeneca

Recruiting

Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736) (ASTEROID)

NSCLC, Stage I

Finland, Norway, Sweden
Sunovion

Completed

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 (PERSISTExt)

Bipolar I Disorder

United States, Poland, Bulgaria, Japan, Slovakia, Hungary, Russian Federation, Czech Republic, Argentina, Chile, France, Serbia
Eli Lilly and Company

Completed

Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed

Bipolar I Disorder

Japan
Beijing Tiantan Hospital
First Affiliated Hospital of Fujian Medical University; Fujian Medical University... and other collaborators

Unknown

Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2 (EAPCAAMHO2)

Arteriovenous Malformations | Cerebral Aneurysm

China
Beijing Tiantan Hospital
First Affiliated Hospital of Fujian Medical University; Fujian Medical University... and other collaborators

Unknown

Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1 (EAPCAAMHO1)

Arteriovenous Malformations | Cerebral Aneurysm

China
John Barnard
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Molecular Determinants of Coronaruy Artery Disease (GeneQuest)

Myocardial Infarction | Coronary Artery Disease | Arteriovenous Malformations

United States
University of Texas Southwestern Medical Center
National Institute of Mental Health (NIMH); Beth Israel Deaconess Medical Center and other collaborators

Completed

Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)

Bipolar I Disorder, Unspecified, With Psychotic Features | Bipolar I Disorder, Unspecified, Without Psychotic Features

United States
Pfizer
Karolinska Institutet; University of Aarhus

Completed

Varenicline Pregnancy Cohort Study

Malformations
University Hospital Pierre Zobda-Quitman

Terminated

Safety and Efficiency Study of Valproic Acid In HAM/TSP (VALPROHAM)

HTLV-I-Associated Myelopathy
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Bipolar I Disorder

United States
Sanofi

Completed

A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting (HomERT)

Pompe Disease | Mucopolysaccharidosis Type I (MPS I)

Italy

Clinical Trials on Chiari I Malformation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations